You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkins and non-Hodgkins lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • +9 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021

Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas Trial in Philadelphia (CART-19)

Completed
Has Results
  • Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
  • CART-19
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 1, 2020

Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)

Completed
Has Results
  • Non Hodgkins Lymphoma
  • Chronic Lymphocytic Leukaemia
  • Lille, France
  • +5 more
Feb 22, 2021

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Lymphoma Trial in Rochester (Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD))

Completed
Has Results
  • Lymphoma
  • Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD)
  • Rochester, Minnesota
    Mayo Clinic
Jan 6, 2020

B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)

Recruiting
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • XmAb13676
  • La Jolla, California
  • +21 more
Oct 20, 2021

Hodgkins Lymphoma Trial in Cologne (Rituximab, BEACOPP escalated)

Completed
  • Hodgkins Lymphoma
  • Cologne, Germany
    1st Dept. of Medicine, Cologne University Hospital
Nov 11, 2020

Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Miami, Florida
  • +2 more
Apr 21, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Relapsed/Refractory Classical Hodgkins Lymphoma
  • Duarte, California
  • +33 more
Jan 5, 2023

Hodgkin Disease Trial in Saint Louis, Winston-Salem, Columbus (Lenalidomide)

Completed
  • Hodgkin Disease
  • Saint Louis, Missouri
  • +2 more
Mar 9, 2021

Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)

Completed
  • Non-Hodgkins Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora kinase inhibitor AT9283
  • Vancouver, British Columbia, Canada
  • +1 more
Apr 6, 2020

Advanced Solid Tumors, Advanced B-cell NHL Trial in Worldwide (Urelumab, Nivolumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Advanced B-cell NHL
  • Urelumab
  • Nivolumab
  • Palo Alto, California
  • +16 more
Sep 10, 2020

Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen

Terminated
  • Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Prostate Cancer, Non-Hodgkins Lymphoma Trial in Los Angeles, San Antonio, Sutton (SGI-1776)

Terminated
  • Prostate Cancer
  • Non-Hodgkins Lymphoma
  • Los Angeles, California
  • +2 more
Jan 13, 2020

Classical Hodgkin's Lymphoma Trial in Worldwide (Panobinostat)

Completed
Has Results
  • Classical Hodgkin's Lymphoma
  • Duarte, California
  • +45 more
Jul 26, 2021

Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Relmacabtagene Autoleucel
  • +2 more
  • Guangzhou, Guangdong, China
  • +12 more
Oct 24, 2023

Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Maywood (Total body irradiation)

Completed
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Total body irradiation
  • Maywood, Illinois
    Patrick Stiff, MD
Aug 19, 2019

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)

Recruiting
  • Non-Hodgkin's Lymphoma
  • ThisCART19A
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Apr 21, 2022

Hodgkin Lymphoma Trial in Saint-Petersburg (Nivolumab 40 mg in 4 ml Injection)

Completed
  • Hodgkin Lymphoma
  • Nivolumab 40 mg in 4 ml Injection
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Jan 22, 2020

Hodgkin Lymphoma Trial (Gemcitabine, Dexamethasone, Cisplatin)

Not yet recruiting
  • Hodgkin Lymphoma
  • (no location specified)
May 9, 2022

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

Completed
Has Results
  • Lymphoma, T-Cell
  • Lymphoma, Extranodal NK-T-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022